Status:
COMPLETED
Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calcium in Subjects With Multiple Abnormal Lipid Levels in the Blood
Lead Sponsor:
Abbott
Conditions:
Dyslipidemia
Coronary Heart Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare the safety and efficacy of fenofibric acid (ABT-335) + rosuvastatin calcium combination therapy with ABT-335 and rosuvastatin calcium monotherapy in subjects wi...
Eligibility Criteria
Inclusion
- Patients with mixed dyslipidemia
Exclusion
- Subjects with unstable medical conditions or medical conditions considered inappropriate in a clinical trial.
- Patients who are taking certain medications or unstable dose of specific medications.
- Women who are pregnant or plan on becoming pregnant or women who are lactating.
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
1445 Patients enrolled
Trial Details
Trial ID
NCT00300482
Start Date
March 1 2006
Last Update
June 10 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Global Medical Information
North Chicago, Illinois, United States, 60064